Advisor Group Holdings, Inc. Purple Biotech Ltd. Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022
BUY
$2.45 - $4.3 $12 - $21
5 New
5 $0
Q1 2021

May 13, 2021
SELL
$3.93 - $6.99 $1,768 - $3,145
-450 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
$3.81 - $4.73 $1,714 - $2,128
450 New
450 $2,000

Others Institutions Holding PPBT

# of Institutions
1
Shares Held
15
Call Options Held
0
Put Options Held
0
View Full List

About PURPLE BIOTECH LTD.

PPBT Quotes by TradingView
  • Ticker PPBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,303,300
  • Market Cap $67M
  • Description
  • Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...
More about PPBT
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email